GHK-Cu 50mg — Research Protocol

GHK-Cu — 50mg protocol. Edit the doses below for the 50mg vial.

Quickstart Highlights

GHK-Cu (glycyl-L-histidyl-L-lysine:copper complex) is a naturally occurring copper peptide with documented roles in wound healing, tissue remodeling, and skin regeneration^[1][2]. Research demonstrates activity in gene regulation related to collagen synthesis, antioxidant defense, and anti-inflammatory pathways^[3][4]. This educational protocol presents practical subcutaneous administration approaches based on clinical practice patterns.

• Reconstitute: Add 3.0 mL sterile water → 16.67 mg/mL concentration.
• Typical range: 1.0–2.0 mg per injection (most common protocols use 5 days/week or 3×/week).
• Easy measuring: At 16.67 mg/mL, 1 unit = 0.01 mL ≈ 167 mcg on a U‑100 insulin syringe.
• Storage: Lyophilized: store at −20 °C (−4 °F) or below; reconstituted: refrigerate at 2–8 °C (35.6–46.4 °F) and use within 30 days.

Dosing & Reconstitution Guide

Standard / Conservative Approach (3 mL = 16.67 mg/mL; 5 days/week)

Phase	Dose	Units (per injection)
Weeks 1–4	1.0 mg (1000 mcg)	6 units (0.06 mL)
Weeks 5–8	1.5 mg (1500 mcg)	9 units (0.09 mL)
Weeks 9–12+	2.0 mg (2000 mcg)	12 units (0.12 mL)

Frequency: Inject once daily, 5 days per week subcutaneously^[5][6]. This gradual titration allows assessment of individual tolerance while maintaining practical injection volumes. For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.

Reconstitution Steps

1. Draw 3.0 mL sterile or bacteriostatic water with a sterile syringe.
2. Inject slowly down the vial wall to minimize foaming.
3. Gently swirl or roll the vial until the peptide fully dissolves (do not shake vigorously).
4. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Alternative Protocol (3 mL = 16.67 mg/mL; 3× weekly)

 

Frequency: Inject 2 mg three times per week (e.g., Monday/Wednesday/Friday)^[6]. This protocol maintains consistent weekly dosing (~6 mg/week) with less frequent injections.

Supplies Needed

P

Plan based on an 8–16 week protocol. Calculations shown for both 5 days/week and 3×/week protocols.

• Peptide Vials (GHK-Cu, 50 mg each):
  • 5 days/week (1.0–2.0 mg/day):
  • 8 weeks (~50 mg total) ≈ 1 vial
  • 12 weeks (~90 mg total) ≈ 2 vials
  • 16 weeks (~130 mg total) ≈ 3 vials
  • 3×/week (2 mg each):
  • 8 weeks (~48 mg) ≈ 1 vial
  • 12 weeks (~72 mg) ≈ 2 vials
  • 16 weeks (~96 mg) ≈ 2 vials

• Insulin Syringes (U‑100, 29–31 gauge):
  • 5 days/week:
  • Per week: 5 syringes
  • 8 weeks: 40 syringes
  • 12 weeks: 60 syringes
  • 16 weeks: 80 syringes
  • 3×/week:
  • Per week: 3 syringes
  • 8 weeks: 24 syringes
  • 12 weeks: 36 syringes
  • 16 weeks: 48 syringes

• Sterile or Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
  • 1 vial protocols: 3 mL → 1 × 10 mL bottle
  • 2 vial protocols: 6 mL → 1 × 10 mL bottle
  • 3 vial protocols: 9 mL → 1 × 10 mL bottle

• Alcohol Swabs: One for the vial stopper + one for the injection site each administration.
  • 5 days/week:
  • Per week: 10 swabs (2 per injection)
  • 8 weeks: 80 swabs → recommend 1 × 100‑count box
  • 12 weeks: 120 swabs → recommend 2 × 100‑count boxes
  • 16 weeks: 160 swabs → recommend 2 × 100‑count boxes
  • 3×/week:
  • Per week: 6 swabs
  • 8 weeks: 48 swabs → recommend 1 × 100‑count box
  • 12 weeks: 72 swabs → recommend 1 × 100‑count box
  • 16 weeks: 96 swabs → recommend 1 × 100‑count box

Protocol Overview

Protocol Overview

Concise summary of common GHK-Cu administration patterns.

• Goal: Support tissue remodeling, wound healing, and skin regeneration through documented biological pathways^[1][2].
• Schedule: Subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
• Dose Range: 1.0–2.0 mg per injection; frequency 3–5 days per week.
• Reconstitution: 3.0 mL per 50 mg vial (16.67 mg/mL) provides practical unit measurements.
• Storage: Lyophilized frozen; reconstituted refrigerated and used within 30 days.

Dosing Protocol

Flexible approaches based on clinical practice patterns.

• Conservative (5 days/week): Start 1.0 mg daily; titrate to 1.5–2.0 mg over 4–8 weeks.
• Alternative (3×/week): Consistent 2.0 mg per injection for simplified scheduling.
• Route: Subcutaneous injection (abdomen, thighs, or upper arms).
• Cycle Length: 8–12 weeks typical; may extend to 16 weeks based on individual goals.
• Timing: Any consistent time of day; rotate injection sites systematically.

Storage Instructions

Proper storage maintains peptide stability and potency.

• Lyophilized (dry powder): Store at −20 °C (−4 °F) or lower in dry, dark conditions^[7][8]. Keep vial tightly sealed with desiccant if possible to minimize moisture exposure.
• Reconstituted (in solution): Refrigerate at 2–8 °C (35.6–46.4 °F) and use within 30 days for optimal potency^[9]. Bacteriostatic water helps inhibit bacterial growth.
• Aliquoting: For longer storage, divide solution into sterile vials and freeze at −20 °C (−4 °F)^[10]. Avoid repeated freeze–thaw cycles as they degrade peptides over time^[11].
• Allow vials to reach room temperature before opening to reduce condensation.

How It Works

GHK-Cu functions as a “signal peptide” that triggers tissue repair processes by chelating copper(II) ions and delivering this essential trace metal to cells in a bioavailable form^[1][9]. Copper is a critical cofactor for enzymes involved in collagen synthesis (lysyl oxidase) and antioxidant defense (superoxide dismutase). Genomic studies show GHK-Cu modulates over 30% of human genes toward a regenerative, anti-aging phenotype^[2][10]. The peptide stimulates production of VEGF and bFGF in fibroblasts, promoting angiogenesis and blood flow to injured tissue^[3]. GHK-Cu also recruits immune cells to injury sites, increases collagen/elastin/glycosaminoglycan synthesis, and regulates matrix metalloproteinases for balanced tissue remodeling^[2][4].

Potential Benefits & Side Effects

Documented effects from research literature and clinical observations.

• Supports wound healing and tissue repair through collagen synthesis and remodeling pathways^[1][2].
• Demonstrates positive regulatory effects on genes related to antioxidant enzymes, growth factors, and anti-inflammatory signaling^[3][4].
• Shows activity in nervous system function and cognitive pathways in preclinical models^[16].
• Generally well tolerated; most common side effects are mild injection-site reactions (temporary redness, itching) with subcutaneous administration.
• No official human dosing guidelines exist as GHK-Cu is not FDA-approved; protocols are based on clinical practice and empirical use^[5].

References

• PMC – The Potential of GHK as an Anti-Aging PeptideComprehensive review of GHK-Cu mechanisms: copper delivery, anti-inflammatory effects, tissue repair
• PMC – Regenerative and Protective Actions of the GHK-Cu PeptideGene expression, skin remodeling, collagen synthesis, clinical cosmetic study results
• Int. J. Med. Sci. – Tripeptides in Wound Healing and Skin RegenerationGHK-Cu stimulates fibroblasts, collagen, angiogenesis; wound healing review
• PubMed – Topically Applied GHK as an Anti-Wrinkle PeptideReview of GHK/GHK-Cu in anti-aging skincare; collagen, elastin, GAG production
• Stanford PAN Facility – Peptide Synthesis FAQsPeptide storage guidelines: −20°C long-term, room temp stability, moisture prevention
• JPT Peptide Technologies – How to Reconstitute PeptidesBest practices for peptide reconstitution, storage at 4°C, avoiding freeze-thaw cycles
• MedlinePlus – Giving an Insulin InjectionNIH guidance on subcutaneous injection technique, site selection, 45° angle
• PMC – GHK-Cu in Prevention of Oxidative Stress and Degenerative ConditionsSafety margin, copper delivery mechanisms, systemic wound healing doses
• MDPI – Effect of Human Peptide GHK on Gene ExpressionGene modulation analysis; antioxidant, anti-anxiety, regenerative activities; safety data
• PMC – GHK Peptide Prevents Sleep-Deprived Learning ImpairmentPreclinical neuroprotective effects; anti-inflammatory action in aging mice